BEST3 trial findings
8 December 2020, 00:00 to 31 December 2021, 00:00
The headline findings
Professors Rebecca Fitzgerald and Peter Sasieni discuss the headline findings of the practice-changing BEST3 trial. BEST3 tested the Cytosponge against usual care for detecting the pre-cancerous condition Barrett's Oesophagus. They are joined by Dr Nick Swart for the health economics analysis.
At this event
Academic Director of King's Clinical Trials Unit
Search for another event